View in Other Languages

Bluechiip Limited

ASX:BCT ISIN:AU000000BCT7

Bluechiip Ltd ASX BCTBluechiip Ltd (ASX:BCT) understands that every sample - stem cells, blood, eggs, sperm and other biospecimens - is critical, so our objective is to manage each one with optimal quality in the most efficient way. Bluechiip's advanced management solution is the only one that provides sample temperature with ID in cryogenic environments to. Most importantly, this delivers confidence in every sample.

Bluechiip's unique patented technology is a MEMS-based wireless tracking solution that contains no electronics. It represents a generational change from current tracking methods such as labels (hand-written and pre-printed), barcodes (linear and 2D), and Radio Frequency Identification. Bluechiip tags are either embedded or manufactured into storage products such as vials or bags. Each product can be easily identified, and critical information such as sample temperature, is detected by readers and stored in the Bluechiip software. In addition to functioning in extreme temperatures, the Bluechiip(R) Advanced Sample management solution can survive autoclaving, gamma irradiation sterilization, humidification, centrifuging, cryogenic storage and frosting.

Bluechiip's technology has applications in healthcare, including in cryogenic storage facilities (biobanks and biorepositories), pathology, clinical trials and forensics. Other key markets include cold-chain logistics/supply chain, security/defence, industrial/manufacturing and aerospace/aviation.

Bluechiip: Delivering confidence in every sample.

 

     

News

Bluechiip Limited (ASX:BCT) Open Briefing

🕔4/28/2022 3:03:18 PM 709

Open Briefing interview with Bluechiip Limited (ASX:BCT) (FRA:1BL) MD Andrew McLellan. In this Open Briefing Andrew discusses sales growth accelerating and expected to continue, following the launch of Bluechiip's own product range in November 2021.

Read Full Article

Bluechiip Limited (ASX:BCT) Quarterly Activities Report

🕔4/28/2022 2:58:43 PM 492

Bluechiip Limited (ASX:BCT) (FRA:1BL), a leader in the development of advanced sample management solutions for harsh environments, is pleased to release the Group's Appendix 4C - Quarterly Cashflow report and update for the quarter ended 31 March 2022.

Read Full Article

Bluechiip Limited (ASX:BCT) Open Briefing Interview with MD Andrew McLellan

🕔1/27/2022 9:54:20 AM 1824

In this Open Briefing(R), Bluechiip Limited (ASX:BCT) (FRA:1BL) MD Andrew McLellan discusses cash receipts from initial orders and deliveries of own product range, expectation for increasing revenues based on existing orders and growing enquiry pipeline, new patent award and developer kit sales and OEM negotiations.

Read Full Article

Bluechiip Limited (ASX:BCT) Quarterly Activities Report

🕔1/27/2022 9:49:25 AM 1449

Bluechiip Limited (ASX:BCT) (FRA:1BL), a leader in the development of advanced sample management solutions for harsh environments, is pleased to release its Appendix 4C - Quarterly Cashflow report and update for the quarter ended 31 December 2021.

Read Full Article

Bluechiip Limited (ASX:BCT) Secures FDA Registration and CE IVD Certification

🕔11/30/2021 10:05:01 AM 2677

Bluechiip Limited (ASX:BCT) (FRA:1BL), a leader in the development of advanced sample management solutions for harsh environments, today announced the recent registration of Bluechiip's own branded cryovials with the United States.

Read Full Article

Bluechiip Limited (ASX:BCT) Open Briefing Interview with Andrew McLellan

🕔10/28/2021 4:28:58 PM 2439

In this Open Briefing(R) interview, Bluechiip Limited (ASX:BCT) (FRA:1BL) MD Andrew McLellan discusses the September quarter 4C, License and Development agreement with US-based Fujifilm Irvine Scientific and the first sales of Bluechiip's own consumables.

Read Full Article

Bluechiip Limited (ASX:BCT) Quarterly Activities Report

🕔10/28/2021 4:24:23 PM 1469

Bluechiip Limited (ASX:BCT) (FRA:1BL) is pleased to release its Appendix 4C - Quarterly Cashflow report and update for the quarter ended 30 September 2021.

Read Full Article

Bluechiip Limited (ASX:BCT) License Agreement with Fujifilm Irvine Scientific

🕔10/26/2021 9:29:23 AM 1889

Bluechiip Limited (ASX:BCT) (FRA:1BL), a leader in the development of sample tracking technology for cryogenic environments, today announced that it has signed a two-year Licence and Development Agreement with California-based FUJIFILM Irvine Scientific, Inc. (FISI).

Read Full Article

Bluechiip Limited (ASX:BCT) FY21 Annual Report

🕔8/31/2021 8:00:48 AM 2371

Bluechiip Limited's (ASX:BCT) (FRA:1BL) unique patented technology is a MEMS-based wireless tracking solution that contains no electronics. It represents a generational change from current tracking methods such as labels.

Read Full Article

Bluechiip Limited (ASX:BCT) Quarterly Activities Report

🕔7/28/2021 1:07:54 PM 2599

Bluechiip Limited (ASX:BCT) (FRA:1BL), a developer and leader in wireless tracking solutions for the healthcare and life science, security, defence and manufacturing industries is pleased to release its Appendix 4C - Quarterly Cashflow report and update for the quarter ended 30 June 2021.

Read Full Article
###

60,308 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 178) (Last 30 Days: 792) (Since Published: 50109) 

Company Data

    Headquarters
  • 1 Dalmore Drive
    Caribbean Business Park
    Scoresby VIC 3179 AUSTRALIA
  • Telephone
  • +61-3-9763-9763 
  • Fax
  • +61-3-9763-9764 
  • Principal Sector
  • Infrastructure & Technology 
  • Principal Industry
  • Healthcare 
  • Homepage
  • www.bluechiip.com

Company Reports

Presentations

Research Report

Quarterly Report

Social Media